<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Puig N</submitter><funding>Generalitat de Catalunya</funding><funding>Instituto de Salud Carlos III</funding><pagination>E300</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6722802</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(8)</volume><pubmed_abstract>Electronegative low-density lipoprotein (LDL(-)) is a minor LDL subfraction that is present in blood with inflammatory and apoptotic effects. We aimed to evaluate the role of sphingolipids ceramide (Cer), sphingosine (Sph), and sphingosine-1-phosphate (S1P) in the LDL(-)-induced effect on monocytes. Total LDL was subfractioned into native LDL and LDL(-) by anion-exchange chromatography and their sphingolipid content evaluated by mass spectrometry. LDL subfractions were incubated with monocytes in the presence or absence of enzyme inhibitors: chlorpromazine (CPZ), d-erythro-2-(N-myristoyl amino)-1-phenyl-1-propanol (MAPP), and N,N-dimethylsphingosine (DMS), which inhibit Cer, Sph, and S1P generation, respectively. After incubation, we evaluated cytokine release by enzyme-linked immunosorben</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>The Role of Distinctive Sphingolipids in the Inflammatory and Apoptotic Effects of Electronegative LDL on Monocytes.</pubmed_title><pmcid>PMC6722802</pmcid><funding_grant_id>2017-SGR-1149</funding_grant_id><funding_grant_id>CIBERDEM CB07/08/0016</funding_grant_id><funding_grant_id>FIS PI13/00364 and FIS PI16/00471</funding_grant_id><pubmed_authors>Puig N</pubmed_authors><pubmed_authors>Estruch M</pubmed_authors><pubmed_authors>Benitez S</pubmed_authors><pubmed_authors>Sanchez-Quesada JL</pubmed_authors><pubmed_authors>Jin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Role of Distinctive Sphingolipids in the Inflammatory and Apoptotic Effects of Electronegative LDL on Monocytes.</name><description>Electronegative low-density lipoprotein (LDL(-)) is a minor LDL subfraction that is present in blood with inflammatory and apoptotic effects. We aimed to evaluate the role of sphingolipids ceramide (Cer), sphingosine (Sph), and sphingosine-1-phosphate (S1P) in the LDL(-)-induced effect on monocytes. Total LDL was subfractioned into native LDL and LDL(-) by anion-exchange chromatography and their sphingolipid content evaluated by mass spectrometry. LDL subfractions were incubated with monocytes in the presence or absence of enzyme inhibitors: chlorpromazine (CPZ), d-erythro-2-(N-myristoyl amino)-1-phenyl-1-propanol (MAPP), and N,N-dimethylsphingosine (DMS), which inhibit Cer, Sph, and S1P generation, respectively. After incubation, we evaluated cytokine release by enzyme-linked immunosorben</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2025-04-04T19:02:05.041Z</modification><creation>2019-09-14T07:05:32Z</creation></dates><accession>S-EPMC6722802</accession><cross_references><pubmed>31344975</pubmed><doi>10.3390/biom9080300</doi></cross_references></HashMap>